Copyright Reports & Markets. All rights reserved.

Global and Japan Lung Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Immunoassays
    • 1.2.3 Flow Cytometry
    • 1.2.4 Rapid Tests
    • 1.2.5 Molecular Assays
    • 1.2.6 Tissue Arrays
    • 1.2.7 Circulating Tumor Cells
    • 1.2.8 Pharmacodiagnostics
    • 1.2.9 Biomarkers
    • 1.2.10 Other
  • 1.3 Market by Application
    • 1.3.1 Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Industrial
    • 1.3.3 Healthcare
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Lung Cancer Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Lung Cancer Diagnostics Growth Trends by Regions
    • 2.2.1 Lung Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lung Cancer Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Lung Cancer Diagnostics Players by Market Size
    • 3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue
  • 3.4 Global Lung Cancer Diagnostics Market Concentration Ratio
    • 3.4.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2019
  • 3.5 Key Players Lung Cancer Diagnostics Area Served
  • 3.6 Key Players Lung Cancer Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Lung Cancer Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Lung Cancer Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lung Cancer Diagnostics Market Size (2015-2026)
  • 6.2 North America Lung Cancer Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Lung Cancer Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Lung Cancer Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Lung Cancer Diagnostics Market Size (2015-2026)
  • 7.2 Europe Lung Cancer Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Lung Cancer Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Lung Cancer Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Lung Cancer Diagnostics Market Size (2015-2026)
  • 8.2 China Lung Cancer Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Lung Cancer Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Lung Cancer Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Lung Cancer Diagnostics Market Size (2015-2026)
  • 9.2 Japan Lung Cancer Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Lung Cancer Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Lung Cancer Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Lung Cancer Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Lung Cancer Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Lung Cancer Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Lung Cancer Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Roche Diagnostics
    • 11.1.1 Roche Diagnostics Company Details
    • 11.1.2 Roche Diagnostics Business Overview
    • 11.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
    • 11.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020))
    • 11.1.5 Roche Diagnostics Recent Development
  • 11.2 BioMérieux
    • 11.2.1 BioMérieux Company Details
    • 11.2.2 BioMérieux Business Overview
    • 11.2.3 BioMérieux Lung Cancer Diagnostics Introduction
    • 11.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.2.5 BioMérieux Recent Development
  • 11.3 Qiagen
    • 11.3.1 Qiagen Company Details
    • 11.3.2 Qiagen Business Overview
    • 11.3.3 Qiagen Lung Cancer Diagnostics Introduction
    • 11.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.3.5 Qiagen Recent Development
  • 11.4 Advpharma
    • 11.4.1 Advpharma Company Details
    • 11.4.2 Advpharma Business Overview
    • 11.4.3 Advpharma Lung Cancer Diagnostics Introduction
    • 11.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.4.5 Advpharma Recent Development
  • 11.5 AIT Austrian Institute of Technology
    • 11.5.1 AIT Austrian Institute of Technology Company Details
    • 11.5.2 AIT Austrian Institute of Technology Business Overview
    • 11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
    • 11.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.5.5 AIT Austrian Institute of Technology Recent Development
  • 11.6 Courtagen Life Sciences
    • 11.6.1 Courtagen Life Sciences Company Details
    • 11.6.2 Courtagen Life Sciences Business Overview
    • 11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
    • 11.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.6.5 Courtagen Life Sciences Recent Development
  • 11.7 DiagnoCure
    • 11.7.1 DiagnoCure Company Details
    • 11.7.2 DiagnoCure Business Overview
    • 11.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
    • 11.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.7.5 DiagnoCure Recent Development
  • 11.8 BioMark Diagnostics
    • 11.8.1 BioMark Diagnostics Company Details
    • 11.8.2 BioMark Diagnostics Business Overview
    • 11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
    • 11.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.8.5 BioMark Diagnostics Recent Development
  • 11.9 Mayo Clinic
    • 11.9.1 Mayo Clinic Company Details
    • 11.9.2 Mayo Clinic Business Overview
    • 11.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
    • 11.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.9.5 Mayo Clinic Recent Development
  • 11.10 HalioDx SAS
    • 11.10.1 HalioDx SAS Company Details
    • 11.10.2 HalioDx SAS Business Overview
    • 11.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
    • 11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2015-2020)
    • 11.10.5 HalioDx SAS Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Lung Cancer Diagnostics Scope and Market Size
    Lung Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Immunoassays
    Flow Cytometry
    Rapid Tests
    Molecular Assays
    Tissue Arrays
    Circulating Tumor Cells
    Pharmacodiagnostics
    Biomarkers
    Other

    Market segment by Application, split into
    Industrial
    Healthcare
    Other

    Based on regional and country-level analysis, the Lung Cancer Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Lung Cancer Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Roche Diagnostics
    BioMérieux
    Qiagen
    Advpharma
    AIT Austrian Institute of Technology
    Courtagen Life Sciences
    DiagnoCure
    BioMark Diagnostics
    Mayo Clinic
    HalioDx SAS

    Buy now